HOME >> MEDICINE >> NEWS
Long-term safety results released for breast cancer drugs

Anastrozole is tolerated better than tamoxifen for the treatment of postmenopausal women with early-stage breast cancer after surgery, according to research published in the August issue of The Lancet Oncology. "Use of anastrozole led to a lower occurrence of adverse effects and serious adverse events and significantly fewer withdrawals from treatment than use of tamoxifen", explain the researchers.

The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial compared use of anastrozole with that of tamoxifen in more than 6000 postmenopausal women with breast cancer that had not spread to other parts of the body. The researchers now present data after more than 5 years of follow-up, which show that no new safety concerns have emerged. Overall, adverse events did not differ between the two groups, but significantly fewer patients in the anastrozole group than in the tamoxifen group had adverse events that were related to their treatment or caused them to withdraw from treatment.

The researchers also did a risk benefit analysis of the two drugs, which took into account both the chance that the patients would have a recurrence of their breast cancer and the side-effects caused by their treatment. The analysis showed that anastrozole had a significantly better risk benefit profile, and that this benefit was greatest at 12 years of treatment. The researchers conclude that their findings support the use of anastrozole rather than tamoxifen as the preferred initial treatment after surgery for these women.


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
1-Aug-2006


Page: 1

Related medicine news :

1. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
2. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
3. Long-term aspirin use associated with reduced risk of dying in women
4. Long-term data on safety and effectiveness of antiobesity drugs needed
5. Long-term financial costs associated with prostate cancer treatment
6. Long-term effects of non-alcoholic fatty liver disease
7. Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later
8. Long-term abstinence may resolve many of the neurocognitive deficits associated with alcoholism
9. Long-term ibuprofen regimen after brain injury worsens cognition in animal study
10. Media availability: Long-term survival of heart attack patients with shock
11. Long-term estrogen therapy linked to breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... of Approval for Sunrise Technologies WALI wireless parking lot controller. This advanced LED ... minimizing glare, reducing light trespass, and protecting the night sky against light pollution. ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... it has completed $3 million convertible note financing, which will be used to ... With the funds from this financing, the company will continue to expand its ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... Surgeon with specialty fellowship training in aesthetic surgery of the face, breast, and ... – the only female-owned premier boutique plastic surgery and aesthetic practice in Southwest ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... Just found out your dear friend has ... heartbreaking when your friend or family member shares their diagnosis. Once the shock wears off, ... say the wrong thing? What are the best ways to help? Words are failing me. ...
(Date:8/31/2020)... ... 31, 2020 , ... Genesis Chiropractic Software and Billing ... launch of its integrated, HIPAA compliant, telehealth solution, available to US-based clients immediately. ... 90 seconds. , According to the U.S. Department of Health & Human ...
Breaking Medicine News(10 mins):
(Date:8/26/2020)... ... August 26, 2020 , ... ... Testing division, expands its technology footprint with the addition of Novocyte Quanteon™ ... With industry-leading biomarker solutions, complemented with traditional ligand-binding assays and study management ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... announced that it has entered into definitive agreement to acquire ProCE, a ... on pharmacists and pharmacy technicians. , CEA represents a growing alliance ...
(Date:8/26/2020)... ... August 26, 2020 , ... Crossroads ... has added CHC and CPCO to her name. , That’s thanks to her ... (CHC) and the Certified Professional Compliance Officer (CPCO.) , The CHC is designed ...
Breaking Medicine Technology:
Cached News: